Lars Aagaard
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- CRISPR and Genetic Engineering
- RNA Research and Splicing
- RNA modifications and cancer
Papers in
- Genetics 17
- Virus-based gene therapy research 15
-
- MicroRNA in disease regulation 9
- Co-authors
- John J. Rossi (8 shared papers)Pål Sætrom (3 shared papers)Finn Skou Pedersen (6 shared papers)Ola Snøve (2 shared papers)Jessica V. Alluin (2 shared papers)Arthur D. Riggs (2 shared papers)Bret S.E. Heale (1 shared paper)Palle Villesen (3 shared papers)
- Journals
- Molecular Therapy — Nucleic Acids (7 papers)Nucleic Acids Research (4 papers)Molecular Therapy (3 papers)Human Gene Therapy Methods (3 papers)Molecular Therapy — Methods & Clinical Development (3 papers)
- Partner nations
- DenmarkUnited StatesChina
In The Last Decade
Lars Aagaard
46 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 667
- Molecular Biology 2.0k
- Virology 102
- Genetics 361
- Ophthalmology 105
Countries citing papers authored by Lars Aagaard
This map shows the geographic impact of Lars Aagaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Aagaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Aagaard more than expected).
Fields of papers citing papers by Lars Aagaard
This network shows the impact of papers produced by Lars Aagaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Aagaard. The network helps show where Lars Aagaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Aagaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 746 | |
| 2 | 2007 | 281 | |
| 3 | 2005 | 231 | |
| 4 | 2007 | 213 | |
| 5 | 2004 | 140 | |
| 6 | 2015 | 107 | |
| 7 | 2009 | 94 | |
| 8 | 2008 | 90 | |
| 9 | 2015 | 73 | |
| 10 | 2019 | 57 | |
| 11 | 2015 | 49 | |
| 12 | 2007 | 46 | |
| 13 | 2014 | 40 | |
| 14 | 2023 | 35 | |
| 15 | 2012 | 33 | |
| 16 | 2016 | 31 | |
| 17 | 2018 | 29 | |
| 18 | 2008 | 29 | |
| 19 | 2022 | 26 | |
| 20 | 2017 | 23 |
About Lars Aagaard
Lars Aagaard is a scholar working on Genetics, Cancer Research, Molecular Biology, Ophthalmology and Virology, having authored 47 papers that have together received 2.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (15 papers), Virus-based gene therapy research (15 papers), CRISPR and Genetic Engineering (10 papers), Advanced biosensing and bioanalysis techniques (9 papers), MicroRNA in disease regulation (9 papers), Retinal Development and Disorders (6 papers), Chromosomal and Genetic Variations (5 papers) and Retinal Diseases and Treatments (5 papers). The work is most often cited by research in Cancer Research (667 citations), Molecular Biology (2.0k citations), Virology (102 citations), Genetics (361 citations) and Ophthalmology (105 citations). Lars Aagaard has collaborated with scholars based in Denmark, United States and China. Frequent co-authors include John J. Rossi, Pål Sætrom, Finn Skou Pedersen, Ola Snøve, Jessica V. Alluin, Arthur D. Riggs, Bret S.E. Heale, Palle Villesen, Thomas Gryesten Jensen and Thomas J. Corydon. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Nucleic Acids Research, Molecular Therapy, Human Gene Therapy Methods and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.